A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 Months of Age) With Mild to Moderate Plaque Psoriasis

Trial Profile

A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 Months of Age) With Mild to Moderate Plaque Psoriasis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Calcitriol (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 05 Apr 2016 Planned number of patients changed from 140 to 100 as reported by ClinicalTrials.gov record.
    • 05 Apr 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Aug 2017 as reported by ClinicalTrials.gov record.
    • 19 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top